ASPIRIN DISPUTE
Drug Firm Loses Case (N.Z. Press Assn.—Copyright) SYDNEY, April 2. For 25 years Bayer Pharma Pty., Ltd., a Sydney drug company, had falsely represented that Bayer aspirin sold by it was an original product, Mr Justice Myers said in an Equity Court judgment today. He also said the firm had made other false representations in advertisements for its aspirin and other products. The misrepresentations since 1939 made the trade in Bayer products fraudulent and barred the firm obtaining any relief at law. Bayer Pharma Pty., Ltd., had applied for an injunction against Henry H. York and Company, Pty., Ltd., of Botany, from using the name Bayer or the Bayer cross on pharmaceutical goods.
Bayer Pharma is a subsidiary of Sterling Drug, Inc., of the United States.
Henry H. York, chemical distributors, is a former agent for Farbenfabriken Bayer A.G., of West Berlin. The hearing lasted 14 months. Witnesses called numbered 291, and about 1100 exhibits tendered as evidence.
Mr Justice Myers said the hearing of the suit had been a reproach to the Australian legal system. He dismissed the suit with costs.
Counsel for Bayer Pharma said he thought the firm would appeal.
Permanent link to this item
https://paperspast.natlib.govt.nz/newspapers/CHP19640403.2.117
Bibliographic details
Press, Volume CIII, Issue 30406, 3 April 1964, Page 11
Word Count
195ASPIRIN DISPUTE Press, Volume CIII, Issue 30406, 3 April 1964, Page 11
Using This Item
Stuff Ltd is the copyright owner for the Press. You can reproduce in-copyright material from this newspaper for non-commercial use under a Creative Commons BY-NC-SA 3.0 New Zealand licence. This newspaper is not available for commercial use without the consent of Stuff Ltd. For advice on reproduction of out-of-copyright material from this newspaper, please refer to the Copyright guide.
Acknowledgements
This newspaper was digitised in partnership with Christchurch City Libraries.
Log in